Aerogen Pharma Limited

This study is testing whether adding an inhaled surfactant medicine to standard breathing support helps premature babies with respiratory distress syndrome (RDS) more than standard support alone. It will involve about 520 babies born between 26 and 33 weeks of pregnancy who are h…